Advancing wound care and strengthening Ontario’s role as a global innovation leader in health care
Ontario healthcare innovator, MolecuLight Inc., is developing a hand-held optical imaging technology designed to visualize bacteria in real-time at the point-of-care. Founded by Dr. Ralph DaCosta, Scientist at The Princess Margaret Cancer Centre and Techna Institute in partnership with University Health Network, MolecuLight Inc’s. device is revolutionizing wound care and strengthening Ontario’s role as a global innovation leader in health care.
Founded in June 2012 by University Health Network Scientist, Dr. Ralph DaCosta, MolecuLight Inc. has joined the ranks of research hospital spin-off companies strengthening Ontario’s role as a global innovation hub. Located in Toronto’s MaRS Centre, MolecuLight Inc. employs a multidisciplinary team of top researchers, engineers, clinical experts and international business leaders to commercialize its first medical device product for global markets: MolecuLight i:X.
